Embark Ventures is a venture capital firm that focuses on "deep tech" companies at the pre-seed and seed stages. They seek ambitious teams with breakthrough proprietary technology that offers a highly defensible competitive advantage in transforming multi-billion dollar industries across sectors like bio-healthcare, material science, software-computing, robotics-automation, manufacturing-industrial, and sensors-semiconductor.
Their most common stage is series-a (57% of deals). Average disclosed round size is $25.8M (across 7 rounds with reported amounts).
Portfolio
7
Fund Size
$45M
Top Stage
Series A
Last 12 Mo
0
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
7 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Izote Biosciences | Pre-Seed | $2.6M | Oct 2024 |
 CellFE Inc. | Series A | $22M | Sep 2023 |
 SafeAI | Series B | $38M | Dec 2022 |
 Rugged Robotics | Series A | $9.4M | Mar 2022 |
 Parallel Systems | Series A | $49.5M | Jan 2022 |
| VVia Separations | Series B | $38M | Oct 2021 |
| SafeAI | Series A | $21M | Jun 2021 |
Top Co-Investors
Builders VC2 shared
AutoTech Ventures2 shared
Brick & Mortar Ventures2 shared
The Engine1 shared
Safar Partners1 shared
DAG Ventures1 shared
Monta Vista Capital1 shared
Anthos Capital1 shared
Congruent Ventures1 shared
Bee Partners1 shared
FTW Ventures1 shared
Nucleus Capital1 shared
Courtyard Ventures1 shared
Newlab1 shared
Bold Capital Partners1 shared
Morpheus Ventures1 shared
Suffolk Technologies1 shared
Khosla Ventures1 shared
M Ventures1 shared
Cota Capital1 shared
Last updated: 16 April 2026